Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 /
抑制剂/激动剂
药物研究 酶学
/
经典阳性药
小分子阳性药 酶抑制剂 代谢酶
/
葡萄糖苷酶
淀粉葡萄糖苷酶抑制剂 单磷酸肌苷脱氢酶抑制剂 糖尿病
/ Voglibose

伏格列波糖 /Voglibose {[allProObj[0].p_purity_real_show]}

货号：A214654 同义名： AO-128

Voglibose, an N-substituted derivative of valiolamine, can inhibit α-glucosidase and be used to treat hyperglycemia and its concomitant diseases.

Voglibose 化学结构 CAS号：83480-29-9
Voglibose 化学结构
CAS号：83480-29-9
Voglibose 3D分子结构
CAS号：83480-29-9
Voglibose 化学结构 CAS号：83480-29-9
Voglibose 3D分子结构 CAS号：83480-29-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Voglibose 纯度/质量文件 产品仅供科研

货号：A214654 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

• Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
• JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
• BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
• J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
• PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >

Voglibose 生物活性

描述 D-Glucose and insulin levels of plasma are usually high in diabetics especially after food ingestion, and reducing intestinal carbohydrate absorption, such as monosaccharides, which are hydrolyzed by α-glucosidase, is one way to control disorders of carbohydrate metabolism. Voglibose, a α-glucosidase inhibitor, delays the digestion and absorption of carbohydrates and is the aid in the treatment of diabetes[3]. In the case of postprandial glucose excursion, oral administration of voglibose (0.2 mg/kg) reduced the carbohydrate-induced increase in blood glucose without causing sustained hypoglycemia in both normal and neonatal streptozotocin-induced diabetic rats[4]. In prediabetic db/db mice, voglibose decreased the average food consumption by 37% compared with vehicle-treated mice. Furthermore, voglibose treatment increased GLP-1 (glucagon-like peptide-1) secretion, while it decreased plasma glucose-dependent insulinotropic polypeptide (GIP)[5].

Voglibose 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02456428 - Completed - Canada, Quebec ... 展开 >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 收起 <<
NCT02476760 - Completed - Canada, Quebec ... 展开 >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 收起 <<
NCT02685410 HIV Prevention ... 展开 >> STI Prevention 收起 << Not Applicable Completed - United States, Connecticut ... 展开 >> Yale New Haven Hospital New haven, Connecticut, United States, 06510 收起 <<

Voglibose 参考文献

[1]Chen X, Zheng Y, Shen Y. Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors. Curr Med Chem. 2006;13(1):109-16.

[2]Ikenoue T, Okazaki K, et al. Effect of a new hypoglycemic agent, A-4166 [(-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine] , on postprandial blood glucose excursion: comparison with voglibose and glibenclamide. Biol Pharm Bull. 1997 Apr;20(4):354-9.

[3]Chen X, Zheng Y, Shen Y. Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors. Curr Med Chem. 2006;13(1):109-16

[4]Ikenoue T, Okazaki K, Fujitani S, Tsuchiya Y, Akiyoshi M, Maki T, Kondo N. Effect of a new hypoglycemic agent, A-4166 [(-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine], on postprandial blood glucose excursion: comparison with voglibose and glibenclamide. Biol Pharm Bull. 1997 Apr;20(4):354-9

[5]Moritoh Y, Takeuchi K, Hazama M. Combination treatment with alogliptin and voglibose increases active GLP-1 circulation, prevents the development of diabetes and preserves pancreatic beta-cells in prediabetic db/db mice. Diabetes Obes Metab. 2010 Mar;12(3):224-33

Voglibose 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.74mL

0.75mL

0.37mL

18.71mL

3.74mL

1.87mL

37.41mL

7.48mL

3.74mL

Voglibose 技术信息

CAS号83480-29-9
分子式C10H21NO7
分子量 267.276
别名 AO-128
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Sealed in dry,Store in freezer, under -20°C
溶解度

DMSO: 105 mg/mL(392.85 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

H2O: 250 mg/mL(935.36 mM)，配合低频超声助溶
动物实验配方

Tags: Voglibose | 83480-29-9 | Glucosidase Inhibitor | Metabolic Enzyme/Protease | Glucosidase | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Voglibose 纯度/质量文件 | Voglibose 生物活性 | Voglibose 临床数据 | Voglibose 参考文献 | Voglibose 实验方案 | Voglibose 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z